Chapter 4 Impact of the Covid-19 Pandemic
- Introduction
- Impact of Covid-19 on Market
- Changes in Consumption Trends for Health-Related Products
Chapter 5 Market Dynamics
- Market Drivers
- High Incidences of Infectious Diseases
- Increasing Incidences of Chronic Disease
- Increasing Research and Development Budget
- Increasing Healthcare Expenditures
- Restraints and Challenges
- Stringent Regulatory Framework
- High R&D and Marketing Costs
- Opportunities
- Point-Of Care Tests That Minimize Dependency on Lab Testing
- Discovery of New Biomarkers and Advances in Molecular Techniques
Chapter 6 Market Breakdown by Technology
- Microarrays
- Description
- Microfluidic Devices
- Market Size and Forecast
- PCR
- Market Size and Forecast
- In Situ Hybridization
- Labeling Techniques
- In Situ Hybridization Applications
- Fiber Fish
- Her2 Fish Testing
- Market Size and Forecast
- Others
- Trend Toward Single-Cell Measurements
- Market Size and Forecast
Chapter 7 Molecular Diagnostics by Application
- Infectious Diseases
- Market Size and Forecast
- Oncology
- Leukemias
- Chronic Myeloid Leukemia
- Genetic Marker of Chronic Myeloid Leukemia
- Market Size and Forecast
- Pre- and Post-Natal Screening
- Carrier Screening
- Prenatal Diagnostic Testing
- Amniocentesis
- Chorionic Villus Sampling
- Genetic Counseling
- Preimplantation Diagnosis
- Newborn Screening
- Market Size and Forecast
- Identity and Paternity
- Paternity Testing
- Technology
- Accreditation
- Legal Issues
- Veterinary Identity Testing
- Market Size and Forecast
- Others
- Market Size and Forecast
Chapter 8 Market Breakdown by Region
- Global Molecular Diagnostic Market by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Rest of the World
Chapter 9 Regulations and Finance
- Overview
- Europe
- U.S.
- Japan
- Insurance
- Food and Drug Administration Guidelines
- Internal Standards for Dna Diagnostics
- Minimum Information About a Microarray
- Experiment: Miame 2.0
- Microarray Quality Control Project
- Clinical Laboratory Improvement Amendments
- Personalized Medicines and Companion Diagnostics
- FDA Guidelines for in Vitro Companion Diagnostics
- Definition and Use of An Ivd Companion Diagnostic Device
- Review and Approval of Ivd Companion Diagnostic Devices and Therapeutic Products
- Novel Therapeutic Products
- Approval of a Therapeutic Product Without An Approved Ivd Companion Diagnostic Device
- General Policies
- FDA Approved Companion Diagnostics
- Nucleic Acid-Based Tests
- Pharmacogenomics Research Network
Chapter 11 Competitive Landscape
Chapter 12 Company Profiles
- Abbott
- Agilent Technologies Inc.
- Almac Group
- Becton, Dickinson and Co.
- Biomerieux Sa
- Bio-Rad Laboratories Inc.
- Cardinal Health
- Danaher Corp.
- Elitech Group
- General Electric
- Hologic Inc.
- Illumina Inc.
- Myriad Genetics
- Grifols (Novartis Molecular Diagnostics)
- Philips Healthcare
- Qiagen N.V.
- Quest Diagnostics
- Roche Holding AG (F. Hoffmann-La Roche Ltd.)
- Siemens Healthcare
- Thermo Fisher Scientific Inc.
List of Tables
Summary Table: Global Molecular Diagnostic Market, by Region, Through 2026
Table 1: Global HIV Data, 2000-2020
Table 2: Global Leading Causes of Disease, 2004 and 2030
Table 3: National Institutes of Health Funding Estimates for Various Conditions and Diseases, 2014–2019
Table 4: Global Molecular Diagnostic Market, by Technology, Through 2026
Table 5: Global Molecular Diagnostic Market, by Application, Through 2026
Table 6: Global Molecular Diagnostic Market, by Region, Through 2026
Table 7: North American Molecular Diagnostic Market, by Technology, Through 2026
Table 8: North American Molecular Diagnostic Market, by Application, Through 2026
Table 9: North American Molecular Diagnostic Market, by Country, Through 2026
Table 10: U.S. Estimated Number of New Cancer Cases, 2021
Table 11: European Molecular Diagnostic Market, by Technology, Through 2026
Table 12: European Molecular Diagnostic Market, by Application, Through 2026
Table 13: European Molecular Diagnostic Market, by Country, Through 2026
Table 14: Asia-Pacific Molecular Diagnostic Market, by Technology, Through 2026
Table 15: Asia-Pacific Molecular Diagnostic Market, by Application, Through 2026
Table 16: Asia-Pacific Molecular Diagnostic Market, by Country, Through 2026
Table 17: Rest of the World Molecular Diagnostic Market, by Technology, Through 2026
Table 18: Rest of the World Molecular Diagnostic Market, by Application, Through 2026
Table 19: Class I and Class II Exempt Devices
Table 20: Minimum Information About a Microarray Experiment: MIAME 2.0
Table 21: Microarray Quality Control Project
Table 22: U.S. Laboratories CLIA-Certified for Molecular Diagnostics and Number of Disease Tests
Table 23: U.S. Genetic Testing Procedures, by Type, 2015
Table 24: FDA-Approved In Vitro Companion Diagnostic Devices, June 1, 2017
Table 25: Nucleic Acid-Based Tests Cleared or Approved by the Center for Devices and Radiological Health, June 1, 2017
Table 26: Nucleic Acid-Based Tests Cleared or Approved by the Center for Devices and Radiological Health, June 1, 2017
Table 27: Selected Molecular Diagnostics, 2020-2021
Table 28: Global Molecular Diagnostic Market Shares, by Manufacturer, 2020
Table 29: Abbott: Financials, 2016-2020
Table 30: Abbott: Product Portfolio, by Business Segment
Table 31: Abbott: Point of Care Diagnostic Products
Table 32: Abbott: Recent Developments, October 2017-September 2021
Table 33: Agilent Technologies Inc.: Product Portfolio
Table 34: Almac Group: Product Portfolio
Table 35: Becton, Dickinson and Company: Product Portfolio
Table 36: bioMérieux S.A.: Product Portfolio
Table 37: BioRad Laboratories: Product Portfolio
Table 38: Cardinal Health Inc.: Product Portfolio
Table 39: Danaher Corp.: Product Portfolio
Table 40: ELITech Group: Product Portfolio
Table 41: General Electric: Financial Performance, 2019 and 2020
Table 42: General Electric Healthcare: Molecular Diagnostics Products
Table 43: Hologic Inc.: Product Portfolio
Table 44: Illumina Inc.: Product Portfolio
Table 45: Myriad Genetics: Product Portfolio
Table 46: Novartis Molecular Diagnostics: Product Portfolio
Table 47: Philips Healthcare: Product Portfolio
Table 48: Qiagen N.V.: Product Portfolio
Table 49: Quest Diagnostics: Product Portfolio
Table 50: F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 51: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 52: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 53: F. Hoffmann-La Roche Ltd.: Recent Developments, June 2017-April 2020
Table 54: Siemens Healthcare GmbH: Product Segments
Table 55: Siemens Healthcare GmbH: Molecular Diagnostics Products
Table 56: Siemens Healthcare GmbH: Financials, 2019
Table 57: Siemens Healthcare GmbH: Key Developments
Table 58: Thermo Fisher Scientific: Product Portfolio
Table 59: Thermo Fisher Scientific: Key Developments, 2021
List of Figures
Summary Figure A: Global Molecular Diagnostic Market, by Region, 2019-2026
Summary Figure B: Global Molecular Diagnostic Market Shares, by Region, 2020
Figure 1: Incidences of Diagnosed Infectious Disease, by Country, 2019
Figure 2: Distribution of Malaria Cases, by Country, 2018
Figure 3: Global Projections for Deaths from the Top Three Chronic Diseases, 2005-2030
Figure 4: Increased Incidence of Cancer, 2012 and 2030
Figure 5: Global Distribution of Deaths from Chronic Diseases, 2018
Figure 6: Flow of Funding for Disease Research, 2014-2018
Figure 7: Global Funding in Tuberculosis Research and Development, by Institutions, 2019
Figure 8: Rising Trends in Healthcare Spending, by Institution, 2015-2040
Figure 9: Global Molecular Diagnostic Market Shares, by Technology, 2020
Figure 10: Global Molecular Diagnostic Market, by Technology, 2019-2026
Figure 11: Global Microarray Market, 2019-2026
Figure 12: Global PCR Market, 2019-2026
Figure 13: Global ISH Market, 2019-2026
Figure 14: Global Others Market, 2019-2026
Figure 15: Global Molecular Diagnostic Market Shares, by Application, 2020
Figure 16: Global Molecular Diagnostic Market, by Application, 2019-2026
Figure 17: Global Infectious Disease Market, 2019-2026
Figure 18: Global Oncology Market, 2019-2026
Figure 19: Global Pre- and Post-Natal Screening Market, 2019-2026
Figure 20: Global Identity and Paternity Market, 2019-2026
Figure 21: Global Others Market, 2019-2026
Figure 22: Global Molecular Diagnostic Market Shares, by Region, 2020
Figure 23: North American Molecular Diagnostic Market Shares, by Technology, 2020
Figure 24: North American Molecular Diagnostic Market Shares, by Application, 2020
Figure 25: North American Molecular Diagnostic Market Shares, by Country, 2020
Figure 26: U.S. Molecular Diagnostic Market, 2019-2026
Figure 27: Canadian Molecular Diagnostic Market, 2019-2026
Figure 28: European Molecular Diagnostic Market Shares, by Technology, 2020
Figure 29: European Molecular Diagnostic Market Shares, by Application, 2020
Figure 30: European Molecular Diagnostic Market Shares, by Country, 2020
Figure 31: German Molecular Diagnostic Market, 2019-2026
Figure 32: U.K. Molecular Diagnostic Market, 2019-2026
Figure 33: French Molecular Diagnostic Market, 2019-2026
Figure 34: Italy New Disease Cases, 2020
Figure 35: Italian Molecular Diagnostic Market, 2019-2026
Figure 36: Spain Share of New Cases, 2020
Figure 37: Spanish Molecular Diagnostic Market, 2019-2026
Figure 38: Rest of European Molecular Diagnostic Market, 2019-2026
Figure 39: Asia-Pacific Molecular Diagnostic Market Shares, by Technology, 2020
Figure 40: Asia-Pacific Molecular Diagnostic Market Shares, by Application, 2020
Figure 41: Asia-Pacific Molecular Diagnostic Market Shares, by Country, 2020
Figure 42: China New Cancer Cases, 2020
Figure 43: China New Cancer Cases Share, 2020
Figure 44: Chinese Molecular Diagnostic Market, 2019-2026
Figure 45: Japanese Molecular Diagnostic Market, 2019-2026
Figure 46: Indian Molecular Diagnostic Market, 2019-2026
Figure 47: Rest of Asia-Pacific Molecular Diagnostic Market, 2019-2026
Figure 48: Africa New Cancer Cases, 2020
Figure 49: Rest of the World Molecular Diagnostic Market Shares, by Technology, 2020
Figure 50: Rest of the World Molecular Diagnostic Market Shares, by Application, 2020
Figure 51: U.S. Process for Marketing a Medical Device
Figure 52: Growth in Clinical Laboratory Sites and Disease Testing, 2012-2015
Figure 53: Global Molecular Diagnostic Market Shares, by Manufacturer, 2020
Figure 54: Abbott: Revenue Share, by Region or Country,
Figure 55: Abbott: Revenue Share, by Business Segment
Figure 56: Becton, Dickinson and Company: Annual Revenue, 2018-2020
Figure 57: Becton, Dickinson and Company: Revenue Share, by Region, 2020
Figure 58: Becton, Dickinson and Company: Revenue Share, by Business Segment, 2020
Figure 59: Danaher Corp.: Annual Revenue, 2018-2020
Figure 60: Danaher Corp.: Revenue Share, by Geography, 2020
Figure 61: Danaher Corp.: Revenue Share, by Segment, 2020
Figure 62: General Electric: Revenue Share, by Business Segment, 2020
Figure 63: General Electric Healthcare: Revenue Share, by Region, 2020
Figure 64: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 65: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region or Country, 2019
Figure 66: Siemens Healthcare GmbH: Revenue Share, by Business Segment, 2019
Figure 67: Siemens Healthcare GmbH: Revenue Share, by Region, 2019
Figure 68: Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
Figure 69: Thermo Fisher Scientific: Revenue Share, by Region, 2020
Figure 70: Thermo Fisher Scientific: Revenue Share, by Segment, 2020
